The HIV testing policy of the American Medical Association was recently updated. The updated version has the guidelines for supporting routine HIV test whilst continuing to promote protection of patient privacy and autonomy.
"Understanding and treatment of HIV has grown substantially over the past few decades," Ardis Hoven, an AMA board member, said, adding, "new policy calls on physicians to routinely test consenting adult patients for HIV and reflects the reality that if HIV is detected early patients can lead full and productive lives"
Merck's Experimental HIV Ineffective
New evidence suggests that Merck's experimental HIV vaccine was ineffective among some trial participants with a pre-existing immunity to a common cold virus
Advertisement
CDC in September 2006 released revised recommendations on HIV testing in the U.S. The recommendations advise that HIV tests become a routine part of medical care for residents ages 13 to 64 and that requirements for written consent and pretest counseling be dropped. According to a study published last month in PLoS One, more than 30 states have laws that hamper doctors from implementing the recommendations.
Source: Kaiser Family Foundation
MED/P
MED/P
New Drugs Hold Hope for HIV Patients
Scientists have found three new drugs that may help transform the long-term prognosis for people with the AIDS virus, thus giving hope for chronically infected patients.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest AIDS/HIV News
The 35th World AIDS Day (WAD) marks an opportunity to review strides in HIV prevention, control, and management, acknowledging achievements.
World AIDS Day 2023 focuses on the theme 'Let Communities Lead,' emphasizing the power of the communities most affected by HIV in bringing an end to AIDS.
Young men involved in sexual activity with other guys are less aware and stigmatized to access PrEP, an HIV prevention drug.
Though monkeypox can affect anyone, CDC research states that approximately 40% of people diagnosed with monkeypox in the US also test positive for HIV.
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.